Use of celastrol or its derivatives in the preparation of a product for inhibiting neisseria gonorrhoeae
Tripterygium wilfordii, as a novel inhibitor of Neisseria gonorrhoeae, solves the treatment challenge of multidrug-resistant Neisseria gonorrhoeae by disrupting the bacterial cell membrane structure, achieving significant antibacterial effects and eradication of infection in vivo.
CN121337816BActive Publication Date: 2026-06-16THE FIRST AFFILIATED HOSPITAL OF NAVAL MEDICAL UNIVERSITY OF CHINESE PEOPLES LIBERATION ARMY
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- THE FIRST AFFILIATED HOSPITAL OF NAVAL MEDICAL UNIVERSITY OF CHINESE PEOPLES LIBERATION ARMY
- Filing Date
- 2025-11-21
- Publication Date
- 2026-06-16
Smart Images
Figure CN121337816B_ABST
Abstract
The application provides application of tripterine or a derivative thereof in preparation of a product for inhibiting Neisseria gonorrhoeae, and relates to the technical field of biology and bacteriostasis. Specifically, the application relates to application of tripterine or a derivative thereof in (I) preparation of a Neisseria gonorrhoeae inhibitor; or (II) preparation of a medicine for preventing, relieving and / or treating Neisseria gonorrhoeae infection; a medicine for treating or preventing infection and / or complications caused by Neisseria gonorrhoeae; and a method for inhibiting or preventing growth of Neisseria gonorrhoeae.
Need to check novelty before this filing date? Find Prior Art